CStone Pharmaceuticals (CSPHF) Discusses CS2009 Data Interpretation and Future Clinical Development Strategy Transcript
Source: SeekingAlpha
2025-10-21 06:44:32 ET
CStone Pharmaceuticals (CSPHF) Discusses CS2009 Data Interpretation and Future Clinical Development Strategy October 20, 2025 9:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
CStone Pharmaceuticals (CSPHF) Discusses CS2009 Data Interpretation and Future Clinical Development Strategy Transcript
CStone Pharmaceuticals - Ordinary Shares
NASDAQ: CSPHF
CSPHF Trading
6.54% G/L:
$0.8612 Last:
852 Volume:
$0.8612 Open:
